Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07111988) titled 'Valbenazine in Obsessive Compulsive Disorder' on Aug. 1.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).
Primary Sponsor: University of Chicago
Condition:
Obsessive-Compulsive Disorder
Intervention:
Drug: Valbenazine
Recruitment Status: Not recruiting
Phase: Phase 2
Date of First Enrollment: October 2025
Target Sample Size: 30
To know more, visit https://clinicaltrials.gov/ct2/show/NCT07111988
Published by HT Digital Content Services w...